文献速递腹部CTMR

基于影像学诊断肝细胞癌:肝脏影像报告和数据系统及超越

Imaging-based diagnosis of hepatocellular carcinoma: Liver Imaging Reporting and Data System and beyond.
PubMed 文献 · Br J Radiol · 2025-01-01

肝细胞癌是全球癌症相关死亡的第三大原因,在高危人群中影像学诊断被所有主要指南接受为确诊依据。本综述讨论了多期增强CT和MRI上肝细胞癌的典型影像表现(动脉期明显强化伴门静脉期和/或延迟期廓清和强化包膜),比较了不同学会制定的影像诊断算法在临床范围、诊断算法、目标用户、复杂程度和技术要求等方面的差异,并讨论了影像学超越病灶表征的作用及未来进展。

要点

  • 在高危人群中,典型影像表现(动脉期明显强化、门静脉期和/或延迟期廓清、强化包膜)对肝细胞癌诊断具有高特异度。
  • 不同学会的影像诊断算法均旨在实现高危人群无创诊断肝细胞癌的高特异度和合理敏感度。
  • 各指南在临床范围、诊断算法、目标用户、复杂程度、技术要求及临床和社会经济背景方面存在差异。

核心结论

  • 在高危人群中应用肝细胞癌的明确影像特征可获得高特异度诊断,不同学会的影像诊断算法在多个方面存在差异;影像学在病灶表征之外的作用及该领域的未来进展有待进一步讨论。

研究设计与样本

  • 综述文章,讨论了基于影像学诊断肝细胞癌的多种学会指南及影像学表现差异,并涉及影像学超越病灶表征的作用和未来进展。

关键影像表现/征象

  • 多期增强CT和MRI上肝细胞癌的典型表现为动脉期明显强化伴门静脉期和/或延迟期低强化(廓清)及强化包膜。
  • 在高危人群中应用肝细胞癌的明确影像特征可产生高特异度诊断。

诊断标准与关键数值

  • 在高危人群中应用肝细胞癌的明确影像特征可获得高特异度诊断。
  • 不同学会的影像诊断算法均旨在实现高危人群无创诊断肝细胞癌的高特异度和合理敏感度。

临床应用与阅片要点

  • 在高危人群中,可依据动脉期明显强化伴门静脉期和/或延迟期廓清及强化包膜的典型影像表现进行肝细胞癌的无创诊断。
  • 不同学会指南在临床范围、诊断算法、目标用户、复杂程度和技术要求等方面存在差异,实际应用中需注意这些差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer-related death globally. It is unique among other cancers in the sense that imaging-based diagnosis is accepted as a definite diagnosis among at-risk patients by all major guidelines. The classic imaging finding of HCC on multiphasic contrast-enhanced CT and MRI is hyperenhancement during the arterial phase with hypoenhancement ("washout") and enhancing capsule in the portal venous and/or delayed phases. When distinct imaging features of HCC are applied in patients with high pre-test probability of HCC, they result in high specificity for diagnosis of this entity. There are several imaging-based diagnostic algorithms developed by different societies, all aimed at high specificity and reasonable sensitivity for noninvasive diagnosis of HCC in at-risk population. These guidelines differ in their clinical scope, diagnostic algorithm, intended users, complexity level, and technical requirements as well as their clinical and socioeconomic contexts. The differences between these guidelines and nuances in imaging of HCC are discussed in this review article. Lastly, the role of imaging beyond the lesion characterization and upcoming advancements in this field are discussed.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Haghshomar M, Kierans AS, Kulik L, et al. Imaging-based diagnosis of hepatocellular carcinoma: Liver Imaging Reporting and Data System and beyond. Br J Radiol. 2025. PMID: 40609019. doi:10.1093/bjr/tqaf123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。